The pharmaceutical industry is on the brink of massive transformation driven by cutting-edge technology and strategic ...

Johnson & Johnson is holding its earnings outlook steady despite President Donald Trump moving decisively toward imposing tariffs on the pharmaceutical industry. The administration’s ...

Texas-based Presa Solutions is a 3PL provider for pharmaceutical manufacturers, offering back-end support, including ...

he excluded pharmaceuticals from the new tariffs, likely a relief for the industry under pressure following his prior comments suggesting a 25% tariff on pharmaceutical imports. On Wednesday ...

The study will additionally recommend interventions by the DoP and other line ministries to support the future growth of the pharma and med-tech industry, aiming to become a global leader,” the ...

For decades, organizations have approached data architecture with a monolithic mindset—centralized platforms, complex ...

During a recent panel discussion sponsored by Purdue University, industry leaders explain how the technology is revolutionizing drug development and production ...

Trump has announced 25% tariffs on cars and car parts imported into the US US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was ...

US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was speaking as he announced 25% tariffs on cars and car parts imported into the US.

In particular, for the pharmaceutical industry, these talent shortages bring about a host of difficult challenges. This is due to the specialist nature of roles and the growth and diversification ...

While the labour market may be tight for the pharmaceutical industry, organisations can get ahead of growing pains by prioritising their people. Growing a strong and stable staff is possible ...

However, it appears that the pharma industry has avoided a big blow – for now. A factsheet released by the White House said that finished pharmaceuticals are not subject to the reciprocal tariff.